Obsidian Therapeutics
Obsidian Therapeutics is a private biotechnology company developing engineered cell therapies with controllable genetic switches.
Last updated October 30, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
No content in this language yet.
History
Obsidian Therapeutics is a privately held biotechnology company that has been developing engineered cell therapies. The company's history is not extensively documented in the provided evidence. It is known to operate in the cell and gene therapy space, focusing on controllable genetic switches to regulate therapeutic cell activity. Specific founding details, such as the year and founders, are not available in the evidence. The company remains active and private, with no public listing.
Recent events
Maria Fardis succeeds Peter Barrett as Obsidian board chair[1]
Reported:
Obsidian Therapeutics announced that Maria Fardis had assumed the role of board chair, succeeding Peter Barrett, who would remain on the board.
Obsidian Therapeutics appoints Erin Boyer as VP of Human Resources[2]
Reported:
Obsidian Therapeutics announced the appointment of Erin Boyer as Vice President, Human Resources. She will oversee the company's human resources operations and strategy.
Sources3 sources
Cite this profile: Cite the canonical profile. /brand-wiki/obsidian-therapeutics · Editorial policy · How profiles are compiled